|
Basic information |
| Metabolite name | Choline-containing compounds/N-Acetyl aspartate ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | Choline-containing compounds/N-acetylaspartate ratio; |
| No. of studies | 9 |
|
Relationship between Choline-containing compounds/N-Acetyl aspartate ratio and depression (count: 9) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M215 | Type1 | depression group vs. control group | Basal ganglia | Human | Up |
| Study M220 | Type1 | depression group vs. control group | Orbitofrontal cortex | Human | Up |
| Study M224 | Type1 | depression group vs. control group | Dorsolateral prefrontal cortex | Human | Up |
| Study M232 | Type2 | ECS-treated LH group post-treatment vs. pre-treatment | Hippocampus | Sprague-Dawley rat | Up |
| Study M236 | Type3 | ECT-treated group post-treatment vs. pre-treatment | Hippocampus | Sprague-Dawley rat | Up |
| Study M250 | Type3 | ECT group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M331 | Type1 | stroke with depression group vs. stroke without depression group | Cerebellum | Human | Up |
| Study M449 | Type1 | stroke with depression group vs. stroke without depression group on 14th day after stroke | Cerebellum | Human | Up |
| Study M960 | Type1 | olfactory-bulbectomised group vs. control group | Hippocampus | Wistar rat | Down |